This holding is nearly 88.8 per cent of India's gross domestic product (GDP), the note said; and at the current market value is about 3.1x times the current equity stock holding with Indian households
The South Asian nation's labour market is facing a dual challenge of unemployment and underemployment, Morgan Stanley economists led by Chetan Ahya wrote in a note
Goldman Sachs, Morgan Stanley, and other entities picked up a 5 per cent stake in Dutch paint maker Akzo Nobel India for nearly Rs 765 crore through open market transactions on Wednesday. Citigroup Global Markets Mauritius, Nippon India Mutual Fund (MF), Edelweiss Life Insurance Company, Ward Ferry Management, Societe Generale, Dublin-based Mediolanum International Funds and BNP Paribas Financial Markets are among the entities that have bought stakes in Akzo Nobel India, as per block deal data on the NSE. These entities have collectively purchased over 22.77 lakh shares or 5 per cent in separate deals. The shares were bought at an average price of Rs 3,358.80 apiece, taking the combined deal value to Rs 764.80 crore. Meanwhile, Imperial Chemical Industries, one of the promoters of Akzo Nobel India, offloaded these shares at the same price. After the stake sale, Imperial Chemical Industries' holding in Akzo Nobel India has come down to 45.46 per cent from 50.46 per cent. The combin
Adani Group demands accountability after SEBI cleared it of Hindenburg's charges that triggered a $150 billion market loss and rattled investor confidence in 2023
Morgan Stanley and Nippon India Mutual Fund (MF) are among the investors that bought around 63 lakh shares worth Rs 438 crore of HealthCare Global Enterprises (HCG) from private equity firm CVC Capital Partners through open market transactions, according to the NSE data. Motilal Oswal MF and Plutus Wealth Management are the other two entities that bought shares in HCG. On Wednesday, Morgan Stanley, Nippon India Mutual Fund (MF), Motilal Oswal MF and Plutus Wealth Management purchased 63 lakh equity shares representing a 4.52 per cent stake in Bengaluru-headquartered HCG. The transaction was valued at around Rs 437.85 crore, and was executed at an average price of Rs 695 apiece on the National Stock Exchange (NSE). Meanwhile, Luxembourg-based CVC Capital Partners through its affiliate, Aceso Company Pte Ltd offloaded these shares at the same price. After the stake sale, Aceso Company holding in HCG has come down to 4.24 per cent from 8.76 per cent. Shares of Healthcare Global ...
Morgan Stanley believes the recent demerger has created two distinct businesses catering to different investor risk appetites.
JSW Steel is well-positioned to benefit due to its significant domestic presence and focus on flat steel products, supported by expanding margins from higher HRC prices
Reliance is building out a fully integrated solar supply chain in India at a time when overcapacity is forcing China to rationalise its polysilicon production
The US-headquartered firm sees a compelling case for a re-rating, driven by India's increasing share in global output, stable fiscal and monetary frameworks
Morgan Stanley sees more FY26 earnings downgrades for NBFCs and advises investors to focus on stocks with strong fundamentals and valuation safety amid sector volatility
The shares were purchased at an average price of Rs 522.70 apiece, taking the transaction value to Rs 577.84 crore
Morgan Stanley has increased its Sensex target to 89,000 by June 2026, citing improving growth conditions and potential catalysts such as US trade deals and capital expenditure
Both global and local banks are considering joining the facility and the deal is expected to be completed by April 2026, pending regulatory approvals
The state government is aiming to develop state-of-the-art infrastructure facilities in an environmentally, economically, and socially sustainable manner
Institutional Securities, which houses the bank's Wall Street operations, posted revenue of $7.6 billion in the second quarter, compared with $7 billion, a year ago
Nuvama maintained a 'Hold' rating on DMart, and revised its target price to ₹4,086 from ₹4,273, citing sustained margin pressure.
Schloss Bangalore has received an 'overweight' rating from Morgan Stanley, with a target price of ₹549
Barclays Plc, Mitsubishi UFJ Financial Group Inc. and UBS Group AG were added to the recent bond and loan sale for Elon Musk's artificial intelligence startup
The proceeds will support xAI's continued development of AI solutions, a data center and its flagship Grok platform
Morgan Stanley, Citigroup Global Markets Singapore and six other entities on Thursday bought a 1.6 per cent stake in logistics solution provider Delhivery for Rs 461 crore through open market transactions. Besides, HDFC Mutual Fund (MF), Axis MF, Tata MF, ASK Asset & Wealth Management, Hill Fort Capital and Hong-Kong-based investment manager Viridian AM purchased shares of the Gurugram-based Delhivery, as per the block deal on the NSE. The entities picked up over 1.19 crore equity shares or 1.6 per cent stake in the company at an average price of Rs 387, taking the combined value to Rs 461 crore. Meanwhile, venture capital firm Nexus Venture Partners, through its affiliates Nexus Opportunity Fund and Nexus Ventures III, offloaded an equal number of shares at the same price. In the March quarter, Nexus Ventures III owned a 5.88 per cent holding in Delhivery. Shares of Delhivery slipped 0.54 per cent to close at Rs 386.05 per piece on the NSE. In April, Delhivery announced the ...